You are here

Validive

Monopar Drops Lead Candidate after Disappointing Phase III Analysis

BioSpace

Wed, 03/29/23 - 09:51 am

Monopar Therapeutics

clinical trials

severe oral mucositis

Monopar raises IPO Target to $46 Million

CP Wire

Wed, 09/11/19 - 09:57 am

Monopar Therapeutics

severe oral mucositis

Monopar raises IPO Target to $46 Million

Wed, 09/11/19 - 09:53 am

Monopar Therapeutics

severe oral mucositis